These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11173317)

  • 21. Minimally oxidized LDL offsets the apoptotic effects of extensively oxidized LDL and free cholesterol in macrophages.
    Boullier A; Li Y; Quehenberger O; Palinski W; Tabas I; Witztum JL; Miller YI
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1169-76. PubMed ID: 16484596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induced expression of manganese superoxide dismutase by non-toxic concentrations of oxidized low-density lipoprotein (oxLDL) protects against oxLDL-mediated cytotoxicity.
    Shatrov VA; Brüne B
    Biochem J; 2003 Sep; 374(Pt 2):505-11. PubMed ID: 12826016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular signatures determining coronary artery and saphenous vein smooth muscle cell phenotypes: distinct responses to stimuli.
    Deng DX; Spin JM; Tsalenko A; Vailaya A; Ben-Dor A; Yakhini Z; Tsao P; Bruhn L; Quertermous T
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1058-65. PubMed ID: 16456091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelin-1 synthesis and endothelin B receptor expression in human coronary artery smooth muscle cells and monocyte-derived macrophages is up-regulated by low density lipoproteins.
    Haug C; Schmid-Kotsas A; Zorn U; Schuett S; Gross HJ; Gruenert A; Bachem MG
    J Mol Cell Cardiol; 2001 Sep; 33(9):1701-12. PubMed ID: 11549348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies against oxidized low-density lipoprotein for the treatment of vulnerable plaques.
    Nilsson J; Glazer S; Carlsson R
    Curr Opin Investig Drugs; 2006 Sep; 7(9):815-9. PubMed ID: 17002259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RPE cells internalize low-density lipoprotein (LDL) and oxidized LDL (oxLDL) in large quantities in vitro and in vivo.
    Gordiyenko N; Campos M; Lee JW; Fariss RN; Sztein J; Rodriguez IR
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2822-9. PubMed ID: 15277509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atherogenic lipids and endothelial dysfunction: mechanisms in the genesis of ischemic syndromes.
    Adams MR; Kinlay S; Blake GJ; Orford JL; Ganz P; Selwyn AP
    Annu Rev Med; 2000; 51():149-67. PubMed ID: 10774458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidized lipoproteins, altered cell function and atherosclerosis.
    Penn MS; Chisolm GM
    Atherosclerosis; 1994 Aug; 108 Suppl():S21-9. PubMed ID: 7802725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Action of intrinsic low density lipoprotein in the vascular wall. Significance for the pathogenesis of essential hypertension and arteriosclerosis].
    Sachinidis A; Ko Y; Vetter W; Vetter H
    Med Klin (Munich); 1994 Dec; 89(12):662-7. PubMed ID: 7870001
    [No Abstract]   [Full Text] [Related]  

  • 30. [Endothelial dysfunction by oxidized LDL].
    Kume N
    Nihon Ronen Igakkai Zasshi; 2000 May; 37(5):360-2. PubMed ID: 10936924
    [No Abstract]   [Full Text] [Related]  

  • 31. OxLDL stimulates cell proliferation through a general induction of cell cycle proteins.
    Zettler ME; Prociuk MA; Austria JA; Massaeli H; Zhong G; Pierce GN
    Am J Physiol Heart Circ Physiol; 2003 Feb; 284(2):H644-53. PubMed ID: 12529257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Growth factors and cytokines in the pathogenesis of cardiovascular diseases].
    Habenicht AJ; Janssen-Timmen U; Salbach PB; Blattner C; Ziegler R
    Verh Dtsch Ges Inn Med; 1991; 97():467-9. PubMed ID: 1808929
    [No Abstract]   [Full Text] [Related]  

  • 33. [Processes of modification of lipoproteins. Physiological and pathogenetical role of modified lipoproteins].
    Belova LA; Ogloblina OG; Belov AA; Kukharchuk VV
    Vopr Med Khim; 2000; 46(1):8-21. PubMed ID: 10802881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis.
    Heinecke JW
    Atherosclerosis; 1998 Nov; 141(1):1-15. PubMed ID: 9863534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Macrophage stimulating action of endothelin].
    Miwa S
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():632-5. PubMed ID: 15506463
    [No Abstract]   [Full Text] [Related]  

  • 36. Oxidation of LDL, atherogenesis, and apoptosis.
    Napoli C
    Ann N Y Acad Sci; 2003 Dec; 1010():698-709. PubMed ID: 15033814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokines and growth factors in renal disease.
    Noronha IL; Niemir Z; Stein H; Waldherr R
    Nephrol Dial Transplant; 1995; 10(6):775-86. PubMed ID: 7566604
    [No Abstract]   [Full Text] [Related]  

  • 38. [The regulation network of growth factors].
    Keski-Oja J
    Duodecim; 1990; 106(3):219-29. PubMed ID: 1670087
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pathological mechanisms of restenosis after angioplasty. Cell and molecular biology findings--possible new therapeutic approaches].
    Bauriedel G
    Fortschr Med; 1994 Aug; 112(24):322-3. PubMed ID: 7959499
    [No Abstract]   [Full Text] [Related]  

  • 40. [Roles of growth factors and cytokines in atherosclerosis].
    Yasuda O; Fukuo K; Ogihara T
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():586-90. PubMed ID: 11351655
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.